REN and colorectal neoplasm: For example, ECM deposition in liver metastasis of colorectal tumor could enhance angiogenesis and anti-angiogenic therapy resistance, while inhibiting ECM deposition with drugs targeting the renin-angiotensin system could reverse resistance to anti-angiogenic bevacizumab (22).